Board Member
Structure Therapeutics Inc. (GPCR)Equibles does not estimate personal net worth.
Get an email with a short summary when Structure Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get GPCR alertsRaymond Stevens is recorded as Board Member and CEO at Structure Therapeutics Inc. (GPCR). The newest filing on record that lists Raymond Stevens as Board Member and CEO at Structure Therapeutics Inc. (GPCR) is dated April 23, 2026. The proxy statement of Structure Therapeutics Inc. reports total compensation of $8,429,887 for Raymond Stevens in fiscal 2025, including a base salary of $672,094. Disclosed compensation is on record for 4 fiscal years. Raymond Stevens has spoken on 4 investor events across 1 company, most recently for Structure Therapeutics Inc. on September 16, 2026. Structure Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Structure Therapeutics Inc. includes Jun Yoon (CFO), Matthew Lang (COO and General Counsel), Yingli Ma (CTO) and 2 others.
“So we can go from 2.5 milligrams to 180 milligrams. What this really translates into is potentially best-in-class efficacy. So the data that we showed last week was up to 16% weight loss.”
“So we can go from 2.5 milligrams to 180 milligrams. What this really translates into is potentially best-in-class efficacy. So the data that we showed last week was up to 16% weight loss.”
“So, one, we had a great ADA just coming from New Orleans. Dr. Julia Rosenstock gave the opening lecture with our data, our access data. And, you know, I think what we sort of took home from that, you know, we also had a Nature of Medicine publication that came out simultaneously to the presentation on Friday of ADA.”
“I think we've been at Jeffree's every year for the past couple of years.”
Start not stated–present
Last confirmed April 23, 2026
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Structure Therapeutics Inc. (GPCR) | Chief Executive Officer and Director | $672,094 | $8,429,887 |
| 2024 | Structure Therapeutics Inc. (GPCR) | Chief Executive Officer and Director | $634,246 | $5,738,850 |
| 2023 | Structure Therapeutics Inc. (GPCR) | Chief Executive Officer and Director(4) | $595,852 | $7,390,911 |
| 2022 | Structure Therapeutics Inc. (GPCR) | Chief Executive Officer and Director(4) | $487,333 | $747,333 |
